295 Intravenous Fosphenytoin as a Critical Bridge Therapy in Acute Trigeminal Neuralgia Attacks Before and After Microvascular Decompression

View at publisher Summarise with VIRAT
Authors: Shusaku Noro, Toru Hatayama, Yoshiyasu Iwai, Hiroki Toda, Junta Moroi, Bunsho Asayama, Yuki AMANO, Masahiro Okuma, Kaori Honjo, Hirohiko Nakamura
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

INTRODUCTION: Acute trigeminal neuralgia (TN) attacks represent neurosurgical emergencies characterized by intense, debilitating facial pain, leaving neurosurgeons with limited immediate intervention options. Patients awaiting microvascular decompression (MVD) often experience periods without adequate pain control, compromising patient comfort and physician-patient trust. METHODS: RCT: A multicenter, randomized, double-blind, placebo-controlled Phase 3 trial was conducted with 21 patients receiving an initial IFT dose of 18 mg/kg. Pain reduction was assessed using a numerical rating scale (NRS). Real-world analysis: Retrospective data from 41 patients receiving off-label IFT (dose: 9.8–20.7 mg/kg) were analyzed, covering pre- and post-MVD scenarios. RESULTS: RCT findings: IFT significantly reduced pain compared to placebo at 2 hours post-administration (mean NRS change: −6.1 vs. −2.4; P = .008) and markedly decreased attack frequency between the initial and first maintenance doses (2.5 vs. 16.1, respectively). Real-world findings: Rapid pain relief was confirmed, with 97.6% of patients achieving ≥50% NRS reduction within 2 hours. IFT effectively bridged patients to elective MVD without recurrence of severe attacks and provided relief in recurrent acute TN episodes post-MVD, enabling smoother transitions to oral medication. Adverse events in both cohorts were mild, transient, and well-tolerated. CONCLUSIONS: IFT represents a significant advancement in emergency management of acute TN attacks, demonstrating rapid, sustained analgesia in clinical trials and real-world settings. Its routine implementation into neurosurgical practice can enhance patient comfort, facilitate preoperative planning, support postoperative recovery, and preserve essential physician-patient trust.

Fields of Study & Subjects

Trigeminal Neuralgia and Treatments Temporomandibular Joint Disorders Migraine and Headache Studies

Publication details

Journal / source
Neurosurgery
Volume
72
Issue
Supplement_1
Pages
74–74
Publication date
26 March 2026
Language
EN